• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Belarus Pharmaceuticals and Healthcare Report Q4 2009 - Product Image

Belarus Pharmaceuticals and Healthcare Report Q4 2009

  • Published: October 2009
  • Region: Belarus
  • 60 Pages
  • Business Monitor International

The Belarus Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Belarus' pharmaceuticals and healthcare industry.

A brief recession and the devaluation of the local currency have demonstrated that Belarus has not been able to escape the global economic crisis, although sheer lack of integration into the global financial system has done much to blunt its impact. According to BMI, the country’s pharmaceutical sector is forecast to deliver a five-year compound annual growth rate (CAGR) of 6.47% through to 2013 in US dollar terms (10.75% in local currency terms), with total market value in final consumer prices set to reach US$869mn. At the same time, the market will not see US dollar growth return until 2011, when the market is expected to resume its previous double-digit growth.

Relations with Russia remain central to overall strength of the Belarusian economy. After a damaging trade row in July, President Alexander Lukashenko has been eager to push for the implementation of the Customs READ MORE >

EXECUTIVE SUMMARY

SWOT ANALYSIS
Belarus Pharmaceuticals And Healthcare Industry SWOT
Belarus Political SWOT
Belarus Economic SWOT
Belarus Business Environment SWOT

PHARMACEUTICAL BUSINESS ENVIRONMENT RATINGS
Table: Central And Eastern Europe Pharmaceutical Business Environment Ratings For Q409
Limits To Potential Returns
Risks To Realisation Of Returns

MARKET SUMMARY

REGULATORY REGIME
Counterfeit Drugs
Intellectual Property Rights
Pricing And Reimbursement

INDUSTRY DEVELOPMENTS
Epidemiology
Table: Disease Burden In Central And Eastern Europe, DALYs Lost Per 100,000 Population
Healthcare Sector

INDUSTRY FORECAST SCENARIO
Overall Market Forecast
Table: Belarus Drug Market Expenditure, 2004-2013
Key Growth Factors – Industry
Table: Belarus Health Expenditure, 2004-2013
Key Growth Factors – Macroeconomic
Table: Belarus Economic Activity, 2006 – 2013
Prescription Drug Market Forecast
Table: Belarus Prescription Drug Market, 2004-2013 (BYRmn unless otherwise stated)
Table: Top 10 ATC Level 2 Codes In Belarus By Pharmacy Sales, 2007-2008
Table: Top 10 ATC Level 2 Codes In Belarus By Hospital Sales, 2007-2008
Patented Drug Market Forecast
Table: Belarus Patented Drug Market, 2004-2013
Generic Drug Market Forecast
Table: Belarus’s Generic Drug Market, 2004-2013
OTC Drug Market Forecast
Table: Belarus OTC Market, 2004-2013 (BYR mn unless otherwise stated)
Pharmaceutical Export/Import Forecast
Table: Belarus Pharmaceutical Trade Balance, 2004-2013 (US$mn)
Other Healthcare Data Forecasts
Table: Belarus Other Health Indicators, 2004-2013
Key Risks to BMI’s Forecasts

COMPETITIVE LANDSCAPE
Table: The Top 10 Drugmakers In Belarus In 2008 By Pharmacy Sales
Table: The Top 10 Drugmakers In Belarus In 2008 By Hospital Sales
Table: The Top 10 Trade Names In Belarus By Pharmacy Sales, 2008
Domestic Drugmakers
Foreign Drugmakers
Pharmaceutical Wholesale And Retail
Research And Development

COMPANY PROFILES
Belbiopharm
Lekpharm

COUNTRY SNAPSHOT: BELARUS DEMOGRAPHIC DATA
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education, 2000-2005
Table: Vital Statistics, 2005-2030
Section 3: Labour Market And Spending Power
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2000-2012 (US$)
Table: Average Annual Wages, 2005-2009

METHODOLOGY
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

- Belbiopharm
- Lekpharm

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos